Posted by LincolnVop on March 25, 2026 at 11:22:45:
In Reply to: Разъяснительная статья posted by Robertfex on March 17, 2026 at 10:15:35:
Zoya Demidenko: Scientist in Tumor Studies
Zoya Demidenko is a prominent researcher associated with the Department of Cell Stress Science at Roswell Park Oncology Institute in Buffalo, New York. Before that, she was employed at the National Institutes of Health and New York Medical College, establishing a robust background in clinical study.
Her academic work spans several key domains, among them the PI3K/AKT/mTOR molecular pathway, cell cycle control, cellular aging, and cancer science. To date, she has authored more than 46 scientific articles, which have garnered more than 4,100 citations — a testament to the impact of her work.
Among her most significant discoveries lies in elucidating the mechanisms of biological cell aging. Her work demonstrated that when the cell cycle is halted but cellular expansion continues, the cells undergo senescence. Importantly, Zoya Demidenko showed that this shift can be inhibited by medication using compounds such as rapamycin.
Zoya Demidenko has also added greatly to cancer treatment research, notably in the area of selective cell protection — a strategy aimed at shielding normal tissue from chemotherapy whilst leaving tumor cells vulnerable. This method carries considerable promise for lowering the adverse effects of oncological therapy.
Throughout her career, Demidenko has worked with top scientists worldwide, including Dr. Mikhail Blagosklonny. Her research can be found in top-tier journals such as Oncotarget, Cell Cycle, Aging (Albany NY), and Oncogene.
With an h-index of 33, Zoya Demidenko is recognized as a widely cited voice in current biomedical science, with her findings keep to guide our understanding of the way cells age, respond to therapy, and the ways in which cancer may be more successfully combated.
https://www.pinterest.com/zoyademidenko/